ZA923321B - Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus - Google Patents

Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus

Info

Publication number
ZA923321B
ZA923321B ZA923321A ZA923321A ZA923321B ZA 923321 B ZA923321 B ZA 923321B ZA 923321 A ZA923321 A ZA 923321A ZA 923321 A ZA923321 A ZA 923321A ZA 923321 B ZA923321 B ZA 923321B
Authority
ZA
South Africa
Prior art keywords
virus
vaccines
culture
cells infected
recombinant avipox
Prior art date
Application number
ZA923321A
Other languages
English (en)
Inventor
Georges Thiry
Thiry Georges
Didier Colau
Colau Didier
Catherine De Wannemaeker
De Wannemaeker Catherine
Daniel Malarme
Malarme Daniel
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of ZA923321B publication Critical patent/ZA923321B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455Eimeria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA923321A 1991-05-27 1992-05-07 Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus ZA923321B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9100507A BE1004877A3 (fr) 1991-05-27 1991-05-27 Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Publications (1)

Publication Number Publication Date
ZA923321B true ZA923321B (en) 1993-01-27

Family

ID=3885526

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923321A ZA923321B (en) 1991-05-27 1992-05-07 Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus

Country Status (23)

Country Link
EP (1) EP0517292B1 (xx)
JP (1) JP3411307B2 (xx)
KR (1) KR100244601B1 (xx)
CN (1) CN1055501C (xx)
AR (1) AR248045A1 (xx)
AT (1) ATE189480T1 (xx)
AU (1) AU656185B2 (xx)
BE (1) BE1004877A3 (xx)
BR (1) BR9202024A (xx)
CA (1) CA2069594A1 (xx)
DE (1) DE69230627T2 (xx)
DK (1) DK0517292T3 (xx)
ES (1) ES2145000T3 (xx)
HU (1) HU215531B (xx)
IE (1) IE921686A1 (xx)
IL (1) IL101780A (xx)
MX (1) MX9202512A (xx)
NZ (1) NZ242620A (xx)
PT (1) PT517292E (xx)
RU (1) RU2130971C1 (xx)
SG (1) SG49876A1 (xx)
TW (1) TW288048B (xx)
ZA (1) ZA923321B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110505A1 (en) * 1991-07-26 1993-02-18 Enzo Paoletti Infectious bursal disease virus recombinant poxvirus vaccine
AU680609B2 (en) * 1992-01-13 1997-08-07 Virogenetics Corporation Marek's disease virus recombinant poxvirus vaccine
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
GB2396814B (en) 2001-11-30 2006-07-19 Isis Innovation Fowlpox vector
CN102703393A (zh) * 2002-05-16 2012-10-03 巴法里安诺迪克有限公司 表达插入痘病毒基因组中的同源基因的重组痘病毒
WO2005048957A2 (en) * 2003-02-20 2005-06-02 Therion Biologics Corporation Novel insertion sites in pox vectors
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
LT3251691T (lt) 2011-11-30 2020-02-10 Boehringer Ingelheim Animal Health USA Inc. Rekombinantiniai hvt vektoriai, ekspresuojantys paukščių patogenų antigenus, ir jų panaudojimas
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
EP3263129A1 (en) 2016-06-29 2018-01-03 Ceva Sante Animale Duck enteritis virus and the uses thereof
CN117357642A (zh) 2016-12-14 2024-01-09 勃林格殷格翰动物保健美国公司 表达禽病原体的多种抗原的重组hvt载体及其用途
BR112021012434A2 (pt) 2018-12-27 2021-09-28 Ceva Sante Animale Vírus recombinantes e usos dos mesmos
EP4378474A2 (en) 2020-06-17 2024-06-05 Boehringer Ingelheim Vetmedica GmbH Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
JP2538367B2 (ja) * 1988-06-24 1996-09-25 ブリティッシュ・テクノロジー・グループ・リミテッド Fowlpoxウィルスの非必須領域
EP0419666A4 (en) * 1988-12-29 1991-05-15 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus
AU643216B2 (en) * 1989-05-30 1993-11-11 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Also Published As

Publication number Publication date
IE921686A1 (en) 1992-12-02
AU1632392A (en) 1992-12-03
PT517292E (pt) 2000-06-30
SG49876A1 (en) 2002-04-16
TW288048B (xx) 1996-10-11
BE1004877A3 (fr) 1993-02-16
KR920021706A (ko) 1992-12-18
IL101780A0 (en) 1992-12-30
DK0517292T3 (da) 2000-05-08
ATE189480T1 (de) 2000-02-15
RU2130971C1 (ru) 1999-05-27
ES2145000T3 (es) 2000-07-01
HU9201746D0 (en) 1992-08-28
JPH05244939A (ja) 1993-09-24
EP0517292B1 (fr) 2000-02-02
HUT62331A (en) 1993-04-28
JP3411307B2 (ja) 2003-05-26
NZ242620A (en) 1993-09-27
CA2069594A1 (fr) 1992-11-28
BR9202024A (pt) 1993-01-19
HU215531B (hu) 2000-05-28
CN1055501C (zh) 2000-08-16
AU656185B2 (en) 1995-01-27
DE69230627T2 (de) 2000-09-28
CN1069068A (zh) 1993-02-17
MX9202512A (es) 1995-01-31
EP0517292A1 (fr) 1992-12-09
AR248045A1 (es) 1995-05-31
DE69230627D1 (de) 2000-03-09
IL101780A (en) 2000-12-06
KR100244601B1 (ko) 2000-03-02

Similar Documents

Publication Publication Date Title
ZA923321B (en) Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
NO892251D0 (no) Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker.
ZA826154B (en) Infectious bronchitis vaccines for poultry, process for the preparation of such vaccines, process for preventing infectious broachitis and infectious bronchitis virus strain
GB2246784A (en) Herpes virus recombinant poxvirus vaccine
HK153395A (en) Processor for the production of hcmv glycoproteins,antibodies thereto and hcmv vaccines and recombinant vectors therefor
CA2186044A1 (en) Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
AU7501898A (en) Live attenuated virus vaccines for equine encephalitis viruses
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
FR2620459B1 (fr) Virus recombinant de la vaccine
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
GB2264949B (en) Measles virus recombinant poxvirus vaccine
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
AU4090393A (en) Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same
AU6358190A (en) Polypeptide vaccines against foot-and-mouth disease virus
WO1997003187A3 (en) Marek's disease virus genes and their use in vaccines for protection against marek's disease
ZA908189B (en) Infectious bronchitis virus vaccine
EP0198828A4 (en) VACCINE AGAINST THE VIRUSES OF INFECTIOUS BURSAL DISEASE.
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
ZA919198B (en) Measles virus recombinant poxvirus vaccine
AU3748785A (en) Infectious bursal disease virus vaccine
AU6051396A (en) Measles virus recombinant poxvirus vaccine
FR2655855B1 (fr) Protection genetique d'animaux contre l'infection par le virus leucemogene bovin, et provirus et virus recombinant derive de ce virus.
EP0678033A4 (en) VACCINE AGAINST AIDS DERIVED FROM THE REVERTING LIVESTOCK VIRUS.